technetium tc 99m hydroxymethylene diphosphonate has been researched along with Zollinger-Ellison Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cadiot, G; Chosidow, D; Daou, D; Delahaye, N; Faraggi, M; Genin, R; Le Guludec, D; Lebtahi, R; Mignon, M; Peker, MC | 1 |
1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Zollinger-Ellison Syndrome
Article | Year |
---|---|
Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoid Tumor; Digestive System Neoplasms; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotide; Pentetic Acid; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Technetium Tc 99m Medronate; Zollinger-Ellison Syndrome | 1999 |